No abstract available
Publication types
-
Clinical Trial, Phase II
-
Letter
MeSH terms
-
Aged
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Disease-Free Survival
-
Female
-
Humans
-
Male
-
Melphalan / administration & dosage
-
Melphalan / adverse effects
-
Middle Aged
-
Multiple Myeloma / drug therapy*
-
Salvage Therapy
-
Survival Analysis
-
Thalidomide / administration & dosage
-
Thalidomide / adverse effects
-
Treatment Outcome
-
Venous Thrombosis / chemically induced